THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Metropolitan Life Insurance Co/NY's Holding History (CIK: 0000728618)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 2,773 Value ($000) $25 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 3,472 Value ($000) $39 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 3,472 Value ($000) $30 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 3,472 Value ($000) $36 Avg Close $11.04 Range $9.98 - $12.03
Q4 2022
Shares 4,078 Value ($000) $46 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 4,078 Value ($000) $41 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 4,078 Value ($000) $37 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 4,078 Value ($000) $39 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 12,301 Value ($000) $136 Avg Close $8.72 Range $7.30 - $11.24
Q3 2021
Shares 7,532 Value ($000) $56 Avg Close $11.19 Range $6.10 - $15.01
Q1 2021
Shares 13,313 Value ($000) $272 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 14,253 Value ($000) $253 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 14,253 Value ($000) $211 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 14,253 Value ($000) $299 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 14,253 Value ($000) $329 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 13,901 Value ($000) $360 Avg Close $19.43 Range $15.72 - $26.47
Q3 2019
Shares 14,614 Value ($000) $285 Avg Close $20.20 Range $16.00 - $24.34
Q2 2019
Shares 14,614 Value ($000) $239 Avg Close $20.26 Range $15.18 - $25.38
Q1 2019
Shares 14,614 Value ($000) $331 Avg Close $25.36 Range $21.04 - $28.63
Q4 2018
Shares 14,614 Value ($000) $374 Avg Close $27.00 Range $21.70 - $35.48
Q3 2018
Shares 14,022 Value ($000) $458 Avg Close $27.25 Range $22.26 - $32.79
Q2 2014
Shares 18,407 Value ($000) $625 Avg Close $27.05 Range $14.75 - $35.67